A Protective Role of Aryl Hydrocarbon Receptor Repressor in Inflammation and Tumor Growth
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Protective Role of Aryl Hydrocarbon Receptor Repressor in Inflammation and Tumor Growth
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 5, Pages 589
Publisher
MDPI AG
Online
2019-04-29
DOI
10.3390/cancers11050589
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The crystal structure of the AhRR–ARNT heterodimer reveals the structural basis of the repression of AhR-mediated transcription
- (2017) Shunya Sakurai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transgenic Overexpression of Aryl Hydrocarbon Receptor Repressor (AhRR) and AhR-Mediated Induction of CYP1A1, Cytokines, and Acute Toxicity
- (2016) Christoph F.A. Vogel et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Aryl hydrocarbon receptor nuclear translocator (ARNT) isoforms control lymphoid cancer cell proliferation through differentially regulating tumor suppressor p53 activity
- (2016) Kacie A. Gardella et al. Oncotarget
- Balancing intestinal and systemic inflammation through cell type-specific expression of the aryl hydrocarbon receptor repressor
- (2016) Olga Brandstätter et al. Scientific Reports
- Association between dioxin and cancer incidence and mortality: a meta-analysis
- (2016) Jinming Xu et al. Scientific Reports
- Environmental immune disruptors, inflammation and cancer risk
- (2015) Patricia A. Thompson et al. CARCINOGENESIS
- Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance
- (2015) Ola Landgren et al. JAMA Oncology
- Liver Tumor Promotion by 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Dependent on the Aryl Hydrocarbon Receptor and TNF/IL-1 Receptors
- (2014) Gregory D. Kennedy et al. TOXICOLOGICAL SCIENCES
- IL-1 Receptor-Associated Kinase Signaling and Its Role in Inflammation, Cancer Progression, and Therapy Resistance
- (2014) Ajay Jain et al. Frontiers in Immunology
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Polybrominated Dibenzo-p-Dioxins, Dibenzofurans, and Biphenyls: Inclusion in the Toxicity Equivalency Factor Concept for Dioxin-Like Compounds
- (2013) Martin van den Berg et al. TOXICOLOGICAL SCIENCES
- Aryl Hydrocarbon Receptor Repressor (AhRR) Function Revisited: Repression of CYP1 Activity in Human Skin Fibroblasts Is Not Related to AhRR Expression
- (2012) Julia Tigges et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways
- (2012) Vincent F-S Shih et al. NATURE IMMUNOLOGY
- Interaction of aryl hydrocarbon receptor and NF-κB subunit RelB in breast cancer is associated with interleukin-8 overexpression
- (2011) Christoph Franz Adam Vogel et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- Characterization of MCF mammary epithelial cells overexpressing the Arylhydrocarbon receptor (AhR)
- (2009) Patrick S Wong et al. BMC CANCER
- The Aryl Hydrocarbon Nuclear Translocator Alters CD30-Mediated NF- B-Dependent Transcription
- (2009) C. W. Wright et al. SCIENCE
- Regulation of constitutive and inducible AHR signaling: Complex interactions involving the AHR repressor
- (2008) Mark E. Hahn et al. BIOCHEMICAL PHARMACOLOGY
- Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice
- (2008) Shuiping Tu et al. CANCER CELL
- The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers
- (2008) Enrique Zudaire et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting of Aryl Hydrocarbon Receptor-Mediated Activation of Cyclooxygenase-2 Expression by the Indole-3-Carbinol Metabolite 3,3′-Diindolylmethane in Breast Cancer Cells
- (2008) Stephanie C. Degner et al. JOURNAL OF NUTRITION
- Lymphoma and lung cancer in offspring born to pregnant mice dosed with dibenzo[a,l]pyrene: The importance of in utero vs. lactational exposure
- (2008) David J. Castro et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started